Will the increased prevalence of nonalcoholic steatohepatitis (NASH) in the age of better hepatitis C virus therapy make NASH the deadlier disease?

Publisher： John Wiley & Sons Inc

E-ISSN： 1527-3350|54|4|1118-1120

ISSN： 0270-9139

Source： HEPATOLOGY, Vol.54, Iss.4, 2011-10, pp. : 1118-1120

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Management of patients with non‐alcoholic steatohepatitis (NASH) in real life

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 38, Iss. S1, 2018-02 ,pp. : 52-55

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Prevalence of Serum Antibodies toHepatitis C Virus Is Not Increased in Patients with Sarcoidosis

By  

Respiration, Vol. 67, Iss. 5, 2000-10 ,pp. : 592-592

Karger

Access to resources Recommend Favorite

Insulin Resistance, Non-alcoholic Fatty Liver Disease and Hepatitis C Virus Infection

By  

Reviews on Recent Clinical Trials, Vol. 9, Iss. 3, 2014-09 ,pp. : 204-209

Bentham Science Publishers

Access to resources Recommend Favorite

Prevalence and risk factors for biopsy‐proven non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in a prospective cohort of adult patients with gallstones

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 8, 2015-08 ,pp. : 1983-1991

John Wiley & Sons Inc

Access to resources Recommend Favorite

Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B‐cell non‐Hodgkin lymphomas, ANRS HC‐13 lympho‐C study

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 3, 2015-03 ,pp. : 197-203

John Wiley & Sons Inc

Access to resources Recommend Favorite